Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
With an outbreak of measles spreading across 14 states, questions about prevention and treatment are increasingly common. How much do you know about the measles? Test yourself with our short quiz.
All-in-one protection for you and your family's digital journey - across all devices and online experiences. Bitdefender was named a Leader in The Forrester Wave™: Endpoint Security, Q4 2023, a ...
This project has not set up a SECURITY.md file yet.
This project has not set up a SECURITY.md file yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback